MiMedx Group
MDXG
P/S ratio for MiMedx Group (MDXG)
P/S ratio as of May 2024 (TTM): 3.48
According to MiMedx Group's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.4815. At the end of 2023 the company had a P/S ratio of 3.99.
P/S ratio history for MiMedx Group from 2010 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.99 | 238.47% |
| 2022 | 1.18 | -54.96% |
| 2021 | 2.62 | -35.52% |
| 2020 | 4.06 | 44.79% |
| 2019 | 2.81 | 406.88% |
| 2018 | 0.5535 | -87.31% |
| 2017 | 4.36 | 10.09% |
| 2016 | 3.96 | -26.27% |
| 2015 | 5.37 | -48.91% |
| 2014 | 10.5 | -31.8% |
| 2013 | 15.4 | 22.89% |
| 2012 | 12.5 | 16.01% |
| 2011 | 10.8 | -90.18% |
| 2010 | 110 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | 3.52 | 1.06% | 🇮🇪 Ireland |
 Teleflex TFX | 3.46 | -0.58% | 🇺🇸 USA |
 Steris STE | 4.22 | 21.11% | 🇮🇪 Ireland |
 NuVasive NUVA | 1.70 | -51.16% | 🇺🇸 USA |
 Hill-Rom HRC | N/A | N/A | 🇺🇸 USA |
 CryoLife CRY | N/A | N/A | 🇺🇸 USA |